Cells fail acid test

Credit: © Nissim Benvenisty" /> Credit: © Nissim Benvenisty The paper: M.J. Martin et al., "Human embryonic stem cells express an immunogenic nonhuman sialic acid," Nat Med, 11:228-32, 2005. (Cited in 111 papers) The finding: Ajit Varki and colleagues at the University of California, San Diego, showed that human embryonic stem cells incorporate a nonhuman immunogenic sialic acid from nonhuman growth serum in typical cell culture.

Written byAndrea Gawrylewski
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

The paper:

M.J. Martin et al., "Human embryonic stem cells express an immunogenic nonhuman sialic acid," Nat Med, 11:228-32, 2005. (Cited in 111 papers)

The finding:

Ajit Varki and colleagues at the University of California, San Diego, showed that human embryonic stem cells incorporate a nonhuman immunogenic sialic acid from nonhuman growth serum in typical cell culture.

The surprise:

Humans stopped producing the sialic acid, Neu5Gc, after they diverged from the great apes. When grown in traditional culture, Neu5Gc is metabolically incorporated into the embryonic stem cell. Varki calls it a Trojan horse effect; rather than contamination by contact, the cell does not recognize the molecule as foreign, and allows incorporation.

The significance:

"We tend to forget that cell culture is very likely to influence stem cell properties and behavior," writes Paul De Sousa, from the University of Edinburgh, in an Email. "This is especially significant when using stem cells ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies